Human Milk Banking

O'Hare, Esther Marie; Wood, Angela; Fiske, Elizabeth

doi:10.1891/0730-0832.32.3.175

Cited by 14 publications

(8 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While the optimal timing of fortification during feeding advancement has not been established, generally fortification takes place between half to full enteral feeds (80 and 160 mL/kg/d) in very-low BW (VLBW) infants. [ 19 – 21 ] It took about 4 weeks to reach 130 ml/kg/d in the DHM group in our NICU. Because NEC occurs more frequently within the first 2 to 4 weeks of life, [ 22 ] fortification was initiated after enteral feeding was achieved at 130 ml/kg/d to reduce the risk of NEC.…”

Section: Discussionmentioning

confidence: 99%

A retrospective study on the effects of exclusive donor human milk feeding in a short period after birth on morbidity and growth of preterm infants during hospitalization

2017

View full text Add to dashboard Cite

The risks and benefits of feeding preterm formula (PF) versus donor human milk (DHM) in preterm infants are uncertain, and studies evaluating the efficacy of DHM to the morbidities and growth of preterm infants in the neonatal intensive care unit are confused by the need for milk fortification. We aimed to determine and compare the outcome of short-term morbidities in neonatal intensive care unit and growth between premature infants fed exclusively DHM only until a volume of 130 mL/kg/d of enteral feeding was achieved and infants fed with a PF mix after birth. The data of 132 infants with low birth weight of <1500 g and gestational age of less than 32 weeks were considered. Ninety infants were analyzed, of which 86 were discharged alive. The DHM group (n = 36) was made up of infants who were fed exclusively with DHM, whereas the PF group (n = 54) consisted of infants who were fed with a combination of PF and either DHM or human milk, until a volume of 130 mL/kg/d of enteral feeding was achieved. Once feeding in the DHM group progressed to volumes greater than 130 mL/kg/d, infants were fed fortified DHM and PF alternately. One infant (2.8%) in the DHM group had late-onset sepsis or necrotizing enterocolitis compared with 21 (38.9%) in the PF group (adjusted odds ratio 0.05, 95% confidence interval 0.01–0.41); 13 (36.1%) infants in the DHM group had bronchopulmonary dysplasia compared with 38 (70.4%) in the PF group (odds ratio 0.18, 95% confidence interval 0.05–0.41). Although the DHM group demonstrated a comparatively lower rate of weight gain, head circumference increment, and height increment from birth to the age at which an enteral feeding volume of 130 mL/kg/d was achieved, there were no significant differences in these values at 36 weeks’ postmenstrual age between both groups.

show abstract

Section: Discussionmentioning

confidence: 99%

A retrospective study on the effects of exclusive donor human milk feeding in a short period after birth on morbidity and growth of preterm infants during hospitalization

2017

View full text Add to dashboard Cite

show abstract

“…Donated milk is mixed and processed via pasteurization (O'Hare, Wood, & Fiske, 2013). HMBANA banks rigorously screen potential donors for infection, medication, and other lifestyle factors that could lead to milk contamination.…”

Section: Donor Milkmentioning

confidence: 99%

Informal Milk Sharing

Martino

Spatz

2014

McN: The American Journal of Maternal/Child Nursing

View full text Add to dashboard Cite

Human milk is the ideal food for human infants. However, some infants will be in situations wherein there is insufficient human milk to meet their needs. This article addresses formal breast milk donation (donor milk) and informal sharing of breast milk. Healthcare providers are likely to encounter families who access milk by informal breast milk sharing or cross-nursing. Both practices rely heavily on receiving human milk from women who are potentially unscreened for disease, medication, and illicit substances. Therefore, it is important for perinatal nurses to have adequate information to be able to inform these families of the risks and benefits of breast milk sharing. Two case exemplars are provided to illustrate the nuances of informal milk sharing. Implications for practice include providing families with information on health history and laboratory screening as well as safe milk-handling practices.

show abstract

“…Breastfeeding is the natural and best way of feeding an infant, and positively influences the development and health of the infant. Human milk is the perfect food for infants, called "living tissue" by many [1,2] because it not only maintains an ideal balance of nutrients but also contains countless bioactive ingredients such as immunoglobulins, hormones, oligosaccharides and other components [3,4]. One important component is human milk oligosaccharides (HMOs), which are multifunctional glycans, naturally present in human milk.…”

Section: Introductionmentioning

confidence: 99%

Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology

et al. 2020

View full text Add to dashboard Cite

The first months of life are a special time for the health development and protection of infants. Breastfeeding is the natural and best way of feeding an infant, and positively influences their development and health. Breast milk provides the ideal balance of nutrients for the infant and contains countless bioactive ingredients such as immunoglobulins, hormones, oligosaccharides and others. Human milk oligosaccharides (HMOs) are a very important and interesting constituent of human milk, and are the third most abundant solid component after lactose and lipids. They are a structurally and biologically diverse group of complex indigestible sugars. This article will discuss the mechanisms of action of HMOs in infants, such as their anti-adhesive properties, properties modulating the immune system, and impact on bacterial flora development. Many health benefits result from consuming HMOs. They also may decrease the risk of infection by their interactions with viruses, bacteria or protozoa. The commercial use of HMOs in infant formula, future directions, and research on the use of HMOs as a therapy will be discussed.

show abstract

Human Milk Banking

Cited by 14 publications

References 8 publications

A retrospective study on the effects of exclusive donor human milk feeding in a short period after birth on morbidity and growth of preterm infants during hospitalization

A retrospective study on the effects of exclusive donor human milk feeding in a short period after birth on morbidity and growth of preterm infants during hospitalization

Informal Milk Sharing

Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology

Contact Info

Product

Resources

About